ANDIJON VILOYATI MISOLIDA OIV INFEKSIYASI BILAN KASALLANGAN BEMORLARDA ANTIRETROVIRUS TERAPIYANING UZOQ MUDDATLI NATIJALARI
DOI:
https://doi.org/10.5281/zenodo.23533698Keywords:
OIV infeksiyasi, antiretrovirus terapiya, ARVT, CD4 limfotsitlari, virus yuklamasi, sodiqlikAbstract
Maqsad — Andijon viloyatida ARVT olayotgan 615 nafar bemorning uzoq muddatli immunologik va virusologik natijalarini retrospektiv baholash. Davolashga sodiqlik va davolash boshlangan davrlar kesimida CD4 hamda virus yuklamasi tahlil qilindi. CD4 ko‘rsatkichining o‘sishi sodiq guruhda +272,55 hujayra/mkl, sodiq bo‘lmagan guruhda esa −124,84 hujayra/mkl ni tashkil etdi. Virus yuklamasining ikkala o‘lchovi mavjud bo‘lgan 501 nafar bemorda yakuniy supressiya 74,5% ni tashkil etdi.References
1. World Health Organization. (2021). Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: Recommendations for a public health approach. WHO. https://www.who.int/ publications/i/item/9789240031593
2. UNAIDS. (2024). The urgency of now: AIDS at a crossroads. 2024 Global AIDS Update. https://www. unaids.org/en/resources/documents/2024/global-aids-update-2024
3. INSIGHT START Study Group. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine, 373, 795–807. https://doi.org/10.1056/NEJMoa1506816
4. Danel, C., et al. (2015). A trial of early antiretrovirals and isoniazid preventive therapy in Africa. New England Journal of Medicine, 373, 808–822. https://doi.org/10.1056/NEJMoa1507198
5. Cohen, M. S., et al. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375, 830–839. https://doi.org/10.1056/NEJMoa1600693
6. World Health Organization. (2017). HIV drug resistance report 2017. WHO. https://www.who.int/ publications/i/item/9789241512831
7. World Health Organization. (2025). WHO guideline on HIV service delivery: Updated guidance on integration and adherence. https://www.who.int/publications/i/item/9789240113879
8. World Health Organization. (2025). WHO updated recommendations on HIV clinical management: Recommendations for a public health approach. https://www.who.int/publications/i/item/9789240119468
9. Panel on Antiretroviral Guidelines for Adults and Adolescents. (2025). Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. ClinicalInfo, NIH. https://clinicalinfo.hiv.gov/en/guidelines/adultand-adolescent-arv
10. von Elm, E., et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Medicine, 4(10), e296. https:// doi.org/10.1371/journal.pmed.0040296
11. World Health Organization. (2021). Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. WHO. https://www.who.int/publications/i/item/9789240022232
12. UNAIDS. (2023). The path that ends AIDS: UNAIDS global AIDS update 2023. https://www.unaids.org/en/ resources/documents/2023/global-aids-update-2023
13. World Health Organization. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2nd ed.). WHO. https://www.who.int/publications/i/item/9789241549684
14. European AIDS Clinical Society. (2024). EACS Guidelines, version 12.1. https://www.eacsociety.org/ guidelines/eacs-guidelines/
15. World Health Organization. (2024). HIV and AIDS: Fact sheet. https://www.who.int/news-room/fact-sheets/ detail/hiv-aids

